Questions about the COVID-19 shot abound as federal recommendations shift and medical groups issue clashing guidance.

Moderna’s Omicron-adapted COVID-19 vaccines appear to reduce the risk of hospitalization and death in adults who are not pregnant or have a weakened immune system, according to a rapid review ...

A public health expert breaks down the most important public health issues on the agenda for the CDC's vaccine advisory ...

Updated mRNA-1273 vaccine was effective against severe COVID-19 outcomes in older and high-risk adults during the 2024-2025 season.

Updated 2024-2025 COVID-19 vaccines significantly reduced the risk for hospitalization and severe outcomes despite the emergence of new viral lineages.

Feb 26 (Reuters) - ⁠The ⁠U.S. CDC's ⁠vaccine advisory committee will ​discuss and may ‌vote on recommendations ‌for issues ...

The company’s co-founders said they are leaving to start a new mRNA-based company.

Earlier this month, major U.S. medical groups asked a federal judge to block the administration from implementing new guidance that cuts the number of vaccines routinely recommended for children and ...

The Centers for Disease Control and Prevention’s influential vaccine advisory panel will consider issuing recommendations ...

By Kamal Choudhury and Blake Brittain March 3 (Reuters) - Moderna has agreed to pay Genevant Sciences, a subsidiary of ...

Stanford researchers develop breakthrough nasal spray vaccine that could potentially protect against a variety of infections, ...